Physician visits prior to treatment for clinically localized prostate cancer

Archives of Internal Medicine

Volumn 170, Issue 5, 2010, Pages 440-450

  Jang, Thomas L ^a,b   Bekelman, Justin E ^a,c   Liu, Yihai ^a   Bach, Peter B ^a   Basch, Ethan M ^a   Elkin, Elena B ^a   Zelefsky, Michael J ^a   Scardino, Peter T ^a   Begg, Colin B ^a   Schrag, Deborah ^a,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL EVALUATION; COMORBIDITY; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICARE; MULTIMODALITY CANCER THERAPY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; UROLOGY; AMBULATORY CARE; ANALYSIS OF VARIANCE; CANCER REGISTRY; CANCER STAGING; CLINICAL PRACTICE; DECISION MAKING; EPIDEMIOLOGY; GENERAL PRACTICE; GENERAL PRACTITIONER; MANPOWER; METHODOLOGY; ONCOLOGY; PATHOLOGY; PATIENT REFERRAL; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ANTIANDROGEN;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; CHOICE BEHAVIOR; CONFOUNDING FACTORS (EPIDEMIOLOGY); FAMILY PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MEDICAL ONCOLOGY; MEDICARE; NEOPLASM STAGING; OFFICE VISITS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; REFERRAL AND CONSULTATION; RESEARCH DESIGN; RISK FACTORS; SEER PROGRAM; UNITED STATES; UROLOGY;

EID: 77950349543     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.1     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [published online before print May 27, 2009]. CA Cancer J Clin. doi:10.3322/caac.20006.
2. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another? a review of patient decision making for localized prostate cancer. Cancer. 2006;106(9):1865-1874.
3. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969-974. (Pubitemid 28445094)
4. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol. 1988;6(11):1736-1745. (Pubitemid 19089054)
5. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000;283(24):3217-3222. (Pubitemid 30422039)
6. McNaughton Collins M, Barry MJ, Zietman A, et al. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology. 2002;60(4):628-633. (Pubitemid 35246448)
7. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER). http://www.seer.cancer.gov. Accessed June 12, 2009.
8. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
9. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748.
10. American Medical Association. International Classification of Diseases, 9th Revision (ICD-9-CM). Chicago, IL: American Medical Association; 2000.
11. American Medical Association. CPT 98 Physicians' Current Procedural Terminology (CPT/Current Procedural Terminology [Standard Edition]). Chicago, IL: American Medical Association; 1998.
12. Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, Warren JL. Linking physician characteristics and Medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40(8)(suppl):IV-82-IV-95.
13. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267.
14. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346(15):1138-1144.
15. Panageas KS, Schrag D, Riedel E, Bach PB, Begg CB. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med. 2003;139(8):658-665. (Pubitemid 38124537)
16. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993; 46(10):1075-1079, 1081-1090.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
18. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. 2009. http://www.nccn.org/professionals/physician-gls/ PDF/prostate.pdf. Accessed June 12, 2009.
19. Bill-Axelson A, Holmberg L, Ruutu M, et al; Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352(19):1977-1984.
20. Fowler FJ Jr, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104(6):526-532. (Pubitemid 28328764)
21. Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med. 1988;318(6):352-355.
22. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127(8, pt 2):666-674.